Viemed Healthcare Inc (VMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $346.72M
Last updated: Nov 17, 2026 at 4:15 PM ET
Viemed Healthcare Inc (VMD) Stock Chart
Viemed Healthcare (VMD) has a latest price of $9.07 on Nov 17, 2026, 28.1% below its 52-week high of $12.61. Its price rose 41.9% over the past 12 months. The month-end price rose 380.1% since Jan 2018, a compound annual rate of 19.6%.
Price Chart
From Jan 2018 to Oct 2026, its highest month-end close was $11.67 in Jul 2026 and its lowest $2.01 in Jan 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VMD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VMD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 1.5%, and over 6 months it fell 5.6%. The month-end price rose 53.2% over the 3 years through Oct 2026, a compound annual rate of 15.3%.
| Period | Change |
|---|---|
| 1 month | -5.4% |
| 3 months | +1.5% |
| 6 months | -5.6% |
| 12 months | +41.9% |
| 12 months, with dividends | +41.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +53.2% | +15.3% |
| 5 years | +68.8% | +11.0% |
| Since Jan 2018 | +380.1% | +19.6% |
Price by Year
Its best calendar year was 2019, when the price rose 63.2%, and its weakest was 2021, when it fell 32.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.67 | +30.1% |
| 2025 | $7.43 | -7.4% |
| 2024 | $8.02 | +2.2% |
| 2023 | $7.85 | +3.8% |
| 2022 | $7.56 | +44.8% |
| 2021 | $5.22 | -32.7% |
| 2020 | $7.76 | +25.2% |
| 2019 | $6.20 | +63.2% |
Trading Range
The price is 2.3% below its 50-day average of $9.29 and 6.2% below its 200-day average of $9.67.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.07 | |
| 52-week high | $12.61 | -28.1% |
| 52-week low | $6.18 | +46.8% |
| 50-day average | $9.29 | -2.3% |
| 200-day average | $9.67 | -6.2% |
Price Risk
Over 3 years, its largest fall from a peak was 40.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.46 |
| Largest fall, 1 year | -30.5% |
| Largest fall, 3 years | -40.6% |
Valuation
Viemed Healthcare traded at 20.1x earnings at the end of 2025, against a 5-year median of 26.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VMD
What is VMD's 1-year price change?
Viemed Healthcare's price rose 41.9% over the past 12 months. With dividends included, the 12-month total return was 41.9%.
What is VMD's 5-year price change?
Viemed Healthcare's month-end price rose 68.8% over the 5 years through Oct 2026, a compound annual rate of 11.0%. These figures leave out dividends.
What is VMD's 52-week high and low?
Viemed Healthcare's 52-week high is $12.61 and its 52-week low is $6.18. Its latest price of $9.07 on Nov 17, 2026 is 28.1% below the high.
What is VMD's beta?
Viemed Healthcare's 1-year beta against the S&P 500 is 0.46, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 30.5%.
Is the VMD chart free?
Yes. Advanced Charting for VMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VMD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors